Participation Flow Chart
Published: Jul 27th, 2018
*Proton therapy patients will also have the option to take part in a randomized controlled trial. Ask your physician to learn more.
Content Tagged “COMPPARE” 
Study Progress
Published: Jul 27th, 2018
Find out more about how COMPPARE is progressing. We will update the following meters on a monthly basis until our goals are achieved: Site Activation. The COMPPARE Consortium includes 45 […]
PCORI Acknowledgements
Published: Jul 24th, 2018
PCORI Acknowledgement Research reported in this study website was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422). PCORI Disclaimer The views, statements, and opinions presented in this […]
Coordinating Center Staff
Published: Jul 23rd, 2018
Day-to-day administration, communications, project management, financial management, and clinical coordination will be managed by the following Coordinating Center staff: Kari Bastow University of Florida Contracting Coordinator Robin Cacchio, […]
Patient and Caregiver Stakeholders
Published: Jul 23rd, 2018
The Patient and Caregiver Stakeholders are a diverse group of prostate cancer survivors and caregivers who have worked with the PI, co-PI, and co-investigators to develop this study and help […]
Partner Organizations
Published: Apr 9th, 2018
The COMPPARE Consortium is proud to partner with the following organizations:
Site PIs, Co-Investigators, and Researchers
Published: Apr 9th, 2018
The site principal investigators, co-investigators, and researchers will be responsible for supervision of research staff, protocol development, patient accrual, initial data submission review, analysis of outcomes, and generation of PCORI […]
ATC
Published: Apr 9th, 2018
The Advanced Technology Consortium (ATC) will provide an informatics infrastructure and quality assurance process to support the submission, review, and analysis of volumetric imaging and treatment planning data for the […]
Executive Board
Published: Apr 4th, 2018
While the PI will have oversight for the design and conduct of the trial, the Executive Board will review all aspects of the study, accrual progress, conflicts, and resolutions, and […]
